Markets:

Overview

News

Currencies

International

Treasuries

DaVita HealthCare Partner (NY:DVA)

108.12 -1.05 (-0.96%)

Official Closing Price Updated: 7:00 PM EST, Jan 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about DaVita HealthCare Partner

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

3 Red Hot Stocks Flashing Buy Signals: DaVita, Intuitive Surgical, SharkNinja ↗

September 14, 2024

Stocks making new highs tend to make even higher highs, particularly when analysts' positive earnings estimate revisions come rolling in. That’s been precisely the case for Intuitive Surgical,...

Via Talk Markets

Bull Of The Day: Davita - Friday, September 6 ↗

September 06, 2024

Known to be the most volatile month for stocks, September is when many investors rebalance their portfolios to include less risky assets such as equities that provide exposure to essential healthcare...

Via Talk Markets

Top Medical Stocks To Hedge Against The September Effect ↗

September 04, 2024

While the Fed will likely cut interest rates in the coming weeks, September has historically been the most challenging month for stocks. Here are three top medical stocks to hedge against the September...

Via Talk Markets

Topics Economy

Nvidia is Down 21%. Here Are 3 Better Stocks to Buy for the Rest of 2024 ↗

August 13, 2024

The AI chipmaker has enjoyed a tremendous run-up, but its sky-high valuation means there are better stocks to buy than Nvidia.

Via InvestorPlace

Topics Artificial Intelligence

Key Takeaways From DaVita Analyst Ratings ↗

August 08, 2024

Via Benzinga

DaVita (DVA) Q2 2024 Earnings Call Transcript ↗

August 06, 2024

DVA earnings call for the period ending June 30, 2024.

Via The Motley Fool

Topics Earnings

6 Analysts Assess DaVita: What You Need To Know ↗

May 06, 2024

Via Benzinga

DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

Financial Crime Weekly: DaVita Agrees To Pay $34.5M For Kickbacks, Hospice Provider Doles Out $19.4M For False Claims ↗

July 19, 2024

DaVita Inc., a kidney dialysis provider, will pay $34.5 million for allegedly paying kickbacks to competitors and doctors for patient referrals.

Via Benzinga

2 Warren Buffett Stocks to Buy Hand Over Fist and 1 to Avoid ↗

June 15, 2024

As the late Meatloaf once sang, "Two out of three ain't bad."

Via The Motley Fool

Buffett Buys on a Budget: The 3 Cheapest Stocks Held by Berkshire Hathaway ↗

June 11, 2024

You can't go wrong by following in the Oracle's footsteps and buying these cheap Buffett stocks before the market catches on.

Via InvestorPlace

These Warren Buffett Stocks Are Trouncing the S&P 500 so Far This Year. Are They Still Buys? ↗

June 07, 2024

Buffett no doubt likes what he's seeing with these high-flying stocks.

Via The Motley Fool

Topics Stocks

Fresenius SE's Future With Dialysis Company Unclear, Investors Seek Answers ↗

May 17, 2024

Investors urge Fresenius SE to clarify its strategic plans for Fresenius Medical Care after recent deconsolidation. Despite holding a 32% stake, challenges like high dialysis patient mortality and...

Via Benzinga

Tandem Diabetes Catapults Above A Profit-Taking Zone, But DaVita Reverses, Nearly Triggering A Sell Signal ↗

May 03, 2024

Tandem Diabetes stock surged above a profit-taking zone on Friday, but DaVita reversed course and tumbled at the open.

Via Investor's Business Daily

The Big Split: 3 Stock Spinoffs Are Coming. Should You Buy? ↗

May 03, 2024

Stock spinoffs can unlock shareholder value but management sometimes uses them to get rid of unwanted, slow-growing businesses.

Via InvestorPlace

DaVita (DVA) Q1 2024 Earnings Call Transcript ↗

May 02, 2024

DVA earnings call for the period ending March 31, 2024.

Via The Motley Fool

Topics Earnings

DVA Stock Earnings: DaVita Beats EPS, Beats Revenue for Q1 2024 ↗

May 02, 2024

DVA stock results show that DaVita beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

3 Healthcare Stocks With the Potential to Triple Your Investment by 2026 ↗

May 01, 2024

Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.

Via InvestorPlace

Warren Buffett's 3 Best-Performing Stocks So Far in 2024: Are They Buys Now? ↗

April 27, 2024

These high-flying Buffett stocks could be attractive to different kinds of investors.

Via The Motley Fool

Ford, Nvidia Among Top S&P 500 Stocks Monday; Tesla Extends Losses ↗

April 22, 2024

Ford, United Airlines and megacap AI stock Nvidia were big-cap winners.

Via Investor's Business Daily

Topics Artificial Intelligence Stocks

How The Weight-Loss Bonanza Prompted A ResMed Sell-Off — But Could Soon Drive Shares Higher ↗

April 18, 2024

ResMed stock reversed higher Thursday after an analyst suggested weight-loss drugs could drive CPAP use.

Via Investor's Business Daily

The Best Warren Buffett Stocks to Buy With $300 Right Now ↗

April 11, 2024

Even with $300, many Buffett investments are within reach of the average investor.

Via The Motley Fool

3 Soaring, Highly-Ranked Value Stocks To Buy In April ↗

April 06, 2024

The stock market bounced back on Wednesday and looked strong through morning trading Thursday until sellers showed up.

Via Talk Markets

3 High-Dividend ETFs That Could Be Smart Investments Right Now ↗

April 04, 2024

These are three great ways to get income in your portfolio without the hard work of choosing stocks and bonds on your own.

Via The Motley Fool

Topics Bonds ETFs

Warren Buffett's Berkshire Hathaway Owns Over 25% of These 4 Companies (Hint: Apple Isn't One of Them) ↗

March 24, 2024

Berkshire even lists one of these companies as a subsidiary.

Via The Motley Fool

3 No-Brainer Warren Buffett Stocks to Buy Right Now ↗

March 19, 2024

Strong brands and market presence make these three companies attractive investments.

Via The Motley Fool

Why Are Dialysis Provider Stocks Trading Higher On Tuesday? ↗

March 05, 2024

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with semaglutide 1.0 mg compared to placebo. Impact on dialysis stocks

Via Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 05, 2024

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expected fourth-quarter earnings and issued 2024 guidance.

Via Benzinga

NIO Reports Upbeat Earnings, Joins Dave, V2X, Riskified And Other Big Stocks Moving Higher On Tuesday ↗

March 05, 2024

U.S. stocks were lower, with the Dow Jones index falling more than 200 points on Tuesday.

Via Benzinga

Topics Stocks

Why Dialysis Stocks DaVita, Fresenius Soared On Novo's Ozempic News ↗

March 05, 2024

Novo Nordisk tested its diabetes and weight-loss drug in patients with chronic kidney disease.

Via Investor's Business Daily

< Previous 1 2

...

5 6 7 8 9 10 11 12 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.